- 24/7 Wall St.•yesterday
The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the campaign trail. However things look like they could be different in 2017.
- American City Business Journals•2 days ago
Chapel Hill-based Cempra (CEMP) saw its shares boosted Friday after the company announced successful Phase 3 trial results of oral fusidic acid for the treatment of skin infections. The jump is a good sign for Cempra. Ahead of the FDA ruling, Cempra announced the retirement of Prabhavathi Fernandes, the company's former president and CEO.
- 24/7 Wall St.•2 days ago
Shares of Cempra saw an incredible gain on Friday after the company announced the results from its late-stage trial for the treatment of patients with acute bacterial skin and skin structure infections....
CEMP : Summary for Cempra, Inc. - Yahoo Finance
Cempra, Inc. (CEMP)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||4.10 x 2800|
|Ask||4.20 x 4000|
|Day's Range||4.00 - 4.75|
|52 Week Range||2.55 - 26.95|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.81|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|